Leading pharma market access firm to double workforce and revenue amid expansion into the United Kingdom AXIS Consulting has announced a major expansion into the UK market, with its first office to open in Edinburgh, Scotland UNITED KINGDOM: AXIS Consulting has, today, announced the doubling of its workforce and revenue across the next three years, amid an expansion into the United Kingdom’s pharmaceutical market access landscape. The new office, which is situated in Edinburgh, is AXIS’ first UK-based headquarters. Founder and CEO, Brenda Dooley, is affirming the company’s commitment to the market by relocating to the UK next month. AXIS Consulting will continue to work with Irish enterprises, providing access to effective healthcare interventions, with national level reimbursement processes. Alongside this, there will be a core focus on the expansion and development of the newly-entered UK market. AXIS Consulting is a leading provider of strategic market access and health technology assessments (HTAs) for pharmaceutical and biotechnology firms. The firm is experiencing a period of rapid growth and is currently expanding its talented workforce, actively recruiting for five positions across the company, including a commercial lead for the UK, a commercial lead in Ireland, a Value and Analytics lead, a HTA strategy lead, and an administrative associate. The newly announced expansion plan will also see AXIS take its 10 staff to 25-30, over the next three years, with revenue expected to double in this timeframe. AXIS Consulting’s expansion into the UK market represents a major milestone for the company. According to a recent Statista Report, the UK’s pharmaceutical market is among the global top 10 national markets, holding some 2.6 percent of the global pharmaceutical sector. Scotland, where AXIS will have its UK headquarters, has an active and dynamic pharmaceutical market access landscape. Data from the Fraser of Allander Institute shows the value of the pharmaceutical sector in Scotland rose from £690 million in 2019, to £1.65 billion in 2022, reaching its peak during the height of the pandemic. Speaking on the expansion into the UK market, CEO and Founder of AXIS Brenda Dooley, said: “I am delighted to announce AXIS Consulting’s expansion into the United Kingdom’s pharmaceutical market access ecosystem. This is represented beautifully by our new headquarters in Edinburgh, and indeed my own commitment to the region in my decision to relocate with my family next month. This is the first UK base of operations for AXIS and from there we will continue to offer our clients access to a wide range of services to help navigate complex healthcare systems. This period of growth and development has been long in the making and over the years we have forged a deep connection with the Scottish region. Over time we amassed a deep understanding of the unique challenges within this particular pharmaceutical landscape, and indeed the wider UK landscape, and built upon our expertise. AXIS was founded with the individual at its core and our aim is to to be the partner of choice for a select and aligned customer base, delivering expertly customised UK reimbursement submissions.” The worst jobs for taking time off sick revealed - and it’s bad news for healthcare workers • New research has revealed which jobs see the biggest loss of earnings when workers have to call in sick - with healthcare practitioners ranked first • Healthcare practitioners reported 177,650 injury cases last year, resulting in over $927 million in forfeited wages, based on their average salary • The average healthcare worker had to take 12 days off work due to their injuries, which equates to $4,354 deducted from their yearly pay THE MONTHLY ROUND-UP
RkJQdWJsaXNoZXIy Mjk3Mzkz